To clarify the molecular mechanism of LCN2 mediation by IL-6 in the STAT3 pathway, we examined whether LCN2 silencing affected IL-6-promoted STAT3 activation in CRC cells (Figure 3B). Here, STAT3 is linked to colorectal carcinoma.